World Anti Angiogenesis Summit

Venue: Boston

Location: Boston, Massachusetts, United States

Event Date/Time: Jan 24, 2011 End Date/Time: Jan 26, 2011
Report as Spam


Excitement is spreading about the potential of anti-angiogenic therapeutics to prevent tumor growth and become the next generation of blockbuster anticancer drugs. The rational is simple, and the benefits are obvious. But currently there are few examples of successfully developing and commercializing anti-angiogenic agents for the treatment of cancer.

We've already seen the success of Genentech's Avastin, but where's the next blockbuster anticancer drug going to come from?

With an exciting number of antiangiogenic agents in both preclinical and clinical development, you've told us there's no better time for the industry to come together and discuss the most crucial challenges currently preventing angiogenesis inhibitors from unleashing their full potential to fight cancer. You could be joining our angiogenesis and oncology R&D leaders (listed at the top of this page) at the World Anti-Angiogenesis Summit, January 24th-26th 2011 in Boston, MA to find out how you can best harness current angiogenesis research for clinical and commercial success. That's the name of the game at this meeting.